Lena Biosciences
PrivateLast Round
Grant
Aug 1, 2024
Total Funding Raised
$4.86M
Company Overview
Lena Biosciences is a biotechnology company that develops three-dimensional cell culture tools and organ-on-a-chip platforms for drug discovery, predictive toxicology, and personalized medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lena Biosciences Comparables
Compare Lena Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlveoliX AG | 86% | |
| AIM Biotech | 86% | |
| BiomimX | 85% |
Lena Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2024 | ||||
| Accelerator | Jul 11, 2022 | ||||
| Grant | Jun 1, 2022 | ||||
| Grant | Aug 1, 2020 | ||||
| Grant | Jul 1, 2018 | ||||
Grant | Jan 1, 2017 |
Lena Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Marcus Foundation | Grant |
| MassChallenge Israel | Accelerator |
| National Institute of Environmental Health Sciences | Grant |
| National Center for Advancing Translational Sciences | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2024
$2M grant from National Institute of Environmental Health Sciences
- Jun 1, 2022
Secured $300K from the National Center for Advancing Translational Sciences.
Lena Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lena Biosciences's valuation, stock price, and market status.
Is Lena Biosciences a public or private company?
Lena Biosciences is a private company.
What is the current stock price of Lena Biosciences?
Lena Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Lena Biosciences worth (valuation)?
Valuation information for Lena Biosciences is not publicly available.
Can I buy Lena Biosciences stock?
Lena Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lena Biosciences's last funding round?
Lena Biosciences's most recent funding round was Grant on August 1, 2024.
Who are the main investors in Lena Biosciences?
Key investors in Lena Biosciences include The Marcus Foundation, MassChallenge, National Institute of Environmental Health Sciences, National Center for Advancing Translational Sciences, National Science Foundation.
Will Lena Biosciences IPO soon?
No public IPO plans have been announced for Lena Biosciences.
How can I track Lena Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lena Biosciences's secondary market activity and sign up for updates.